Published September 18, 2023 | Version v1

Data for: A catalytic model for SARS-CoV-2 reinfections: Performing simulation-based validation and extending the model to include nth infections

  • 1. South African DSI-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa

Contributors

  • 1. South African DSI-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa

Description

For code and more details see: 

  • inf_for_sbv.RDS - simluated timeseries of primary infections used in the simulation-based validation of reinfections. 
  • inf_for_sbv_third.RDS - simluated timeseries of primary infections used in the simulation-based validation of third infections. 
  • 3_posterior_90_null_correctdata.RData - posterior samples from the MCMC fitting procedure (as used in the manuscript) when not considering a second lambda parameter (to third infections)
  • 3_posterior_90_null_l2_correctdata.RData - posterior samples from the MCMC fitting procedure (as used in the manuscript) when considering a second lambda parameter (to third infections)
  • 3_sim_90_null_correctdata.RDS - simulation results when not considering a second lambda parameter for third infections (as used in the manuscript)
  • 3_sim_90_null_l2_correctdata.RDS - simulation results when considering a second lambda parameter for third infections (as used in the manuscript)

 

Files

Files (183.8 MB)

Name Size Download all
md5:16c20bcd164fb85e303a85d0ea947aa9
740.8 kB Download
md5:c41bdad6da0328193271678c3b7e1145
575.5 kB Download
md5:39bbbb001033684cc30b229df438d491
91.9 MB Download
md5:7ea25a00b665a47b614e2d008cf58187
90.5 MB Download
md5:74457d8b6c4e95e2421c12640e491e9e
2.8 kB Download
md5:fa93f5a48153adef57510581564120a6
5.2 kB Download

Additional details

Related works

Is supplement to
Dataset: https://zenodo.org/record/7426515 (URL)

Funding

Wellcome Trust
Characterization of SARS-CoV-2 transmission dynamics, clinical features and disease impact in South Africa, a setting with high HIV prevalence 221003

References

  • Pulliam JRC, van Schalkwyk C, Govender N, von Gottberg A, Cohen C, Groome MJ, Dushoff J, Mlisana K, Moultrie H. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science. 2022 May 6;376(6593):eabn4947. doi: 10.1126/science.abn4947. Epub 2022 May 6. PMID: 35289632; PMCID: PMC8995029.